Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
13
OTIS Quote, Financials, Valuation and Earnings
Last price:
$93.79
Seasonality move
:
1.42%
Day range:
$92.84 - $93.61
52-week range:
$85.42 - $106.33
Dividend yield:
1.62%
P/E ratio:
23.32x
P/S ratio:
2.68x
P/B ratio:
--
Volume:
1.2M
Avg. volume:
1.9M
1-year change:
4.94%
Market cap:
$37.4B
Revenue:
$14.2B
EPS (TTM):
$4.01
Analysts' Opinion
-
Consensus RatingOtis Worldwide has received a consensus rating of . The company's average rating is a based on 5 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $98.96, Otis Worldwide has an estimated upside of 8.62% from its current price of $93.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $79.00 representing 100% downside risk from its current price of $93.51.
Fair Value
-
According to the consensus of 0 analysts, Otis Worldwide has 8.62% upside to fair value with a price target of $98.96 per share.
OTIS vs. S&P 500
-
Over the past 5 trading days, Otis Worldwide has underperformed the S&P 500 by -4.45% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Otis Worldwide does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Otis Worldwide has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Otis Worldwide reported revenues of $3.5B.
Earnings Growth
-
Otis Worldwide has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Otis Worldwide reported earnings per share of $1.34.
Enterprise value:
43.9B
EV / Invested capital:
17.68x
Price / LTM sales:
2.68x
EV / EBIT:
21.97x
EV / Revenue:
3.09x
PEG ratio (5yr expected):
1.10x
EV / Free cash flow:
32.74x
Price / Operating cash flow:
28.37x
Enterprise value / EBITDA:
20.14x
Gross Profit (TTM):
$4.3B
Return On Assets:
16.18%
Net Income Margin (TTM):
11.48%
Return On Equity:
--
Return On Invested Capital:
68.98%
Operating Margin:
10.23%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $13.8B | $14B | $14.2B | $3.5B | $3.5B | |
| Gross Profit | $4B | $4.1B | $4.3B | $1B | $1.1B | |
| Operating Income | $2B | $2.2B | $2B | $571M | $363M | |
| EBITDA | $2.2B | $2.3B | $2.2B | $617M | $411M | |
| Diluted EPS | $2.91 | $3.31 | $4.01 | $0.91 | $1.34 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.3B | $6.4B | $5.8B | $6.7B | $6.5B | |
| Total Assets | $10.5B | $10.5B | $9.3B | $10.4B | $10.3B | |
| Current Liabilities | $6.3B | $6.4B | $6B | $6.7B | $8.1B | |
| Total Liabilities | $13.9B | $13.7B | $14.1B | $15B | $15B | |
| Total Equity | -$3.4B | -$3.2B | -$4.7B | -$4.6B | -$4.8B | |
| Total Debt | $6.1B | $5.5B | $6.6B | $7.4B | $7.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $1.5B | $1.5B | $306M | $394M | |
| Cash From Investing | $42M | -$227M | -$261M | -$41M | -$113M | |
| Cash From Financing | -$1.7B | -$668M | -$2B | $167M | -$423M | |
| Free Cash Flow | $1.3B | $1.4B | $1.3B | $272M | $362M | |
OTIS
Sector
Market Cap
$37.4B
$764.1M
Price % of 52-Week High
87.94%
78.36%
Dividend Yield
1.62%
0%
Shareholder Yield
3.68%
2.32%
1-Year Price Total Return
4.94%
-1.72%
Beta (5-Year)
--
0.899
Dividend yield:
1.62%
Annualized payout:
$1.31
Payout ratio:
36.11%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$95.30
200-day SMA
Sell
Level
$97.47
Bollinger Bands (100)
Sell
Level
93.86 - 102.5
Chaikin Money Flow
Buy
Level
89.5M
20-day SMA
Sell
Level
$98.76
Relative Strength Index (RSI14)
Sell
Level
29.65
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-90.7159
50-day SMA
Sell
Level
$100.35
MACD (12, 26)
Sell
Level
-1.89
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
111.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3018)
Sell
CA Score
(Annual)
Level (-3.4675)
Buy
Beneish M-Score
(Annual)
Level (-2.5213)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (4.982)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis’ founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.
Stock Forecast FAQ
In the current month, OTIS has received 5 Buy ratings 8 Hold ratings, and 0 Sell ratings. The OTIS average analyst price target in the past 3 months is $98.96.
-
Where Will Otis Worldwide Stock Be In 1 Year?
According to analysts, the consensus estimate is that Otis Worldwide share price will rise to $98.96 per share over the next 12 months.
-
What Do Analysts Say About Otis Worldwide?
Analysts are divided on their view about Otis Worldwide share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Otis Worldwide is a Sell and believe this share price will drop from its current level to $79.00.
-
What Is Otis Worldwide's Price Target?
The price target for Otis Worldwide over the next 1-year time period is forecast to be $98.96 according to 0 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is OTIS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Otis Worldwide is a . 0 of 0 analysts rate the stock a at this time.
-
How Can I Buy Shares Of OTIS?
You can purchase shares of Otis Worldwide via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Otis Worldwide shares.
-
What Is The Otis Worldwide Share Price Today?
Otis Worldwide was last trading at $93.79 per share. This represents the most recent stock quote for Otis Worldwide. Yesterday, Otis Worldwide closed at $93.51 per share.
-
How To Buy Otis Worldwide Stock Online?
In order to purchase Otis Worldwide stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.51% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.86% over the past day.
